-- New approval for VIMPAT® (lacosamide) CV in the U.S. as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older -- All three ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. DENVER — Primary generalized tonic-clonic seizures ...
A phase 3 study assessing the use pregabalin as adjunctive therapy for epilepsy patients 5 to 65 years of age with primary generalized tonic-clonic (PGTC) seizures did not meet its primary endpoint to ...
Credit: Shutterstock. Eprontia is approved for the treatment of partial-onset or primary generalized tonic-clonic seizures and migraine prevention. The Food and Drug Administration (FDA) has approved ...
Hosted on MSN
Scientists map brain network linked to generalized seizures, paving way for new brain stimulation therapies
Generalized epilepsy has traditionally been considered a seizure of the "'whole brain.'" However, new research has challenged this longstanding idea, since carefully targeting specific brain areas ...
LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with ...
Approximately 500,000 women with epilepsy are of childbearing age in the United States. [1] The need for antiepileptic drug treatment should be reassessed in all women with epilepsy who are ...
Substitution monotherapy and add-on therapy were equally effective as a second-line treatment for women with idiopathic generalized epilepsy, with no significant differences in failure rates between ...
A Cleveland Clinic-led initiative has come up with a new risk scoring system for epileptic or seizure disorders of genetic origin. The researchers summed up the risks for a very large number of genes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results